Comorbidities in difficult asthma are independent risk factors for frequent exacerbations, poor control and diminished quality of life

• DOI: 10.1111/resp.12838
• Publication Date: 2016-07-01T01:13:07Z
• Authors: Tunn Ren Tay; Naghmeh Radhakrishna; Fiona Hore‐Lacy; Catherine Smith; Ryan Hoy; Eli Dabscheck; Mark Hew
• Keywords: Adult; Male; Depression; Statistics as Topic; Australia; 610; Comorbidity; Middle Aged; Rhinitis, Allergic; Risk Assessment; Severity of Illness Index; Asthma; 3. Good health; Body Mass Index; 03 medical and health sciences; Sleep Apnea Syndromes; 0302 clinical medicine; Risk Factors; 616; Outcome Assessment, Health Care; Gastroesophageal Reflux; Quality of Life; Humans; Female; Aged

ABSTRACTBackground and objectiveLittle is known about how comorbidities affect difficult asthma patients across different domains of asthma outcomes. We hypothesized that comorbidities in difficult asthma significantly influence asthma outcomes.MethodsWe analysed 90 consecutive patients who underwent systematic assessment at our hospital's difficult asthma clinic. Eight comorbidities were assessed in all patients. They were allergic rhinitis, chronic rhinosinusitis (CRS), gastroesophageal reflux disease, obesity, obstructive sleep apnoea, anxiety or depression, dysfunctional breathing (DB) and vocal cord dysfunction (VCD). Asthma outcomes examined were exacerbation frequency (≥3/year vs <3/year), asthma control using the Asthma Control Test (ACT) and quality of life using the Asthma Quality of Life Questionnaire (AQLQ). Multivariate logistic regression was performed for dichotomous outcomes and linear regression for continuous outcomes. Analyses were adjusted for lung function and absolute blood eosinophils.ResultsIncreasing BMI was an independent risk factor for exacerbations (OR: 1.1, 95% CI: 1–1.1, P = 0.042), lower ACT score (β coefficient: −0.25, 95% CI: −0.37 to −0.12, P < 0.001) and poorer AQLQ (β coefficient: −0.05, 95% CI: −0.09 to −0.02, P = 0.006). DB predicted lower ACT (β coefficient: −2.85, 95% CI: −5 to −0.7, P = 0.01) and AQLQ scores (β coefficient: −0.73, 95% CI: −1.34 to −0.12, P = 0.02). Patients with CRS had more exacerbations (OR: 4, 95% CI: 1.5–10.9, P = 0.006). Patients with VCD had lower AQLQ scores (β coefficient: −0.78, 95% CI: −1.38 to −0.18, P = 0.012).ConclusionComorbidities independently impact a broad spectrum of outcomes in difficult asthma. Systematic evaluation of these conditions is essential in difficult asthma.